The Latest Cardiac and Vascular News
WEST CHESTER, Pa., May 1, 2023 /PRNewswire/ — VESTECK, Inc. is pleased to announce, Scientific Advisory Board member Dr. Dai Yamanouchi has accepted the role of Professor and Chairman of the Department of Vascular Surgery at Fujita Health University, Toyoake City, Japan. Fujita Health University encompasses four hospital campuses. Professor Yamanouchi is also currently an […]
Procedure performed as part of the company’s ongoing CGuardians U.S. Investigational Device Exemption (IDE) trial designed to support potential U.S. marketing approval of the CGuard stent system CGuardians enrollment on track to be completed by the end of Q2 2023 TEL AVIV, Israel, May 01, 2023 (GLOBE NEWSWIRE) — InspireMD, […]
Casana obtained FDA clearance for measuring Heart Rate (HR) and Oxygen Saturation (SpO2) Sensors embedded in the toilet seat enable effortless measurement of these vital signs Casana will pursue subsequent filings, including Systolic and Diastolic Blood Pressure (BP), with the target of an initial product market launch by the end […]
NEW YORK, May 01, 2023 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) disorders, announced today it […]
Krissy Wright joins as CFO and Sandra Statz as EVP of Regulatory Affairs to Support Company’s Mission to Create a World Without Heart Attacks May 01, 2023 09:00 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced today it has […]
LONDON–(BUSINESS WIRE)–Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, today announced that it has completed enrollment in the ALPACAR-360 phase 2 study of zerlasiran (SLN360) in subjects with elevated lipoprotein(a) (“Lp(a)”) […]
Clinical Stage Company Expands Regenerative Medicine Franchise into 4 billion Dollar Aneurysm Market ELK CITY, Idaho–(BUSINESS WIRE)–Therapeutic Solutions International (TSOI) announced formation of a new spin-off company, VasoSome Vascular Inc, focused on treating the “living timebomb” condition of aortic aneurysms using stem cell derived exosomes. The aorta is the body’s […]
ABBOTT PARK, Ill., April 27, 2023 /PRNewswire/ — Abbott (NYSE: ABT) today announced it has completed the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease. The transaction provides Abbott with a complementary solution for treating vascular disease. CSI’s […]
THOUSAND OAKS, Calif., April 27, 2023 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2023. “We delivered 14% volume growth driven by the breadth of our portfolio and strong demand for our products globally,” said Robert A. Bradway, chairman and chief executive officer. “We look forward to closing […]
CAMBRIDGE, Mass., April 28, 2023 /PRNewswire/ — ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS category leader, has announced the release of its AI-driven clinical suite, Neuro Suite. Purpose-built for disease triage, differential diagnostic insights, and care activation in many neurological disease states such as neuro-oncology, dementia, multiple sclerosis, and more, […]
